A private biotechnology company focused on epigenetic reprogramming, backed by Brian Armstrong.
AI-generated insights about NewLimit from various financial sources
Mentioned as a key player in the high-potential longevity and age-reversal sector, which is expected to see a major scientific breakthrough.
Mentioned as a key player in the high-potential longevity and age-reversal sector, which is expected to see a major scientific breakthrough.